Literature DB >> 23375517

Incorporating non-genetic risk factors and behavioural modifications into risk prediction models for colorectal cancer.

Jane M Yarnall1, Daniel J M Crouch, Cathryn M Lewis.   

Abstract

BACKGROUND: Epidemiological studies have identified potentially modifiable risks for colorectal cancer, including alcohol intake, diet and a sedentary lifestyle. Modelling these environmental factors alongside genetic risk is critical in obtaining accurate estimates of disease risk and improving our understanding of behavioural modifications.
METHODS: 14 independent single nucleotide polymorphisms identified though GWAS studies and reported on by the international consortium COGENT were used to model genetic disease risk at a population level. Six well validated environmental risks were selected for modelling together with the genetic risk factors (alcohol intake; smoking; exercise levels; BMI; fibre intake and consumption of red and processed meat). Through a simulation study using risk modelling software, we assessed the potential impact of behavioural modifications on disease risk.
RESULTS: Modelling the genetic data alone leads to 24% of the population being classified as reduced risk; 60% average risk; 10% elevated risk and 6% high risk for colorectal cancer. Adding alcohol consumption to the model reduced the elevated and high risk categories to 9% and 5% respectively. The simulation study suggests that a substantial proportion of individuals could reduce their disease risk profile by altering their behaviour, including reclassification of over 62% of heavy drinkers.
CONCLUSION: Modelling lifestyle factors alongside genetic risk can provide useful strategies to select individuals for screening for colorectal cancer risk. IMPACT: Quantifying the impact of moderating behaviour, particularly related to alcohol intake and obesity levels, is beneficial for informing health campaigns and tailoring prevention strategies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23375517     DOI: 10.1016/j.canep.2012.12.008

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  12 in total

1.  External Validation of Risk Prediction Models Incorporating Common Genetic Variants for Incident Colorectal Cancer Using UK Biobank.

Authors:  Catherine L Saunders; Britt Kilian; Deborah J Thompson; Luke J McGeoch; Simon J Griffin; Antonis C Antoniou; Jon D Emery; Fiona M Walter; Joe Dennis; Xin Yang; Juliet A Usher-Smith
Journal:  Cancer Prev Res (Phila)       Date:  2020-02-18

Review 2.  Cancer risk assessment tools in primary care: a systematic review of randomized controlled trials.

Authors:  J G Walker; S Licqurish; P P C Chiang; M Pirotta; J D Emery
Journal:  Ann Fam Med       Date:  2015-09       Impact factor: 5.166

Review 3.  Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.

Authors:  Hui Peng; Shang-Kui Xie; Mei-Jin Huang; Dong-Lin Ren
Journal:  Tumour Biol       Date:  2013-04-18

4.  Evaluating the predictive value of genetic risk score in colorectal cancer among Chinese Han population.

Authors:  Ding Ye; Danjie Jiang; Simeng Gu; Yingying Mao; Sangni Qian; Shujuan Lin; Qilong Li; Jinhua Yang; Kunhong Zhong; Mingjuan Jin; Kun Chen
Journal:  J Hum Genet       Date:  2019-12-19       Impact factor: 3.172

Review 5.  Risk Prediction Models for Colorectal Cancer: A Systematic Review.

Authors:  Juliet A Usher-Smith; Fiona M Walter; Jon D Emery; Aung K Win; Simon J Griffin
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-13

6.  Assessing Individual Risk for High-Risk Early Colorectal Neoplasm for Pre-Selection of Screening in Shanghai, China: A Population-Based Nested Case-Control Study.

Authors:  Jie Shen; Yiling Wu; Xiaoshuang Feng; Fei Liang; Miao Mo; Binxin Cai; Changming Zhou; Zezhou Wang; Meiying Zhu; Guoxiang Cai; Ying Zheng
Journal:  Cancer Manag Res       Date:  2021-05-12       Impact factor: 3.989

7.  The monocyte to red blood cell count ratio is a strong predictor of postoperative survival in colorectal cancer patients: The Fujian prospective investigation of cancer (FIESTA) study.

Authors:  Feng Peng; Dan Hu; Xiandong Lin; Gang Chen; Binying Liang; Chao Li; Yan Chen; Zhaolei Cui; Hejun Zhang; Jixiu Lin; Xiongwei Zheng; Wenquan Niu
Journal:  J Cancer       Date:  2017-03-12       Impact factor: 4.207

8.  A colorectal cancer prediction model using traditional and genetic risk scores in Koreans.

Authors:  Keum Ji Jung; Daeyoun Won; Christina Jeon; Soriul Kim; Tae Il Kim; Sun Ha Jee; Terri H Beaty
Journal:  BMC Genet       Date:  2015-05-09       Impact factor: 2.797

9.  Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer.

Authors:  Jan Pander; Lieke van Huis-Tanja; Stefan Böhringer; Tahar van der Straaten; Hans Gelderblom; Cornelis Punt; Henk-Jan Guchelaar
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

10.  Impaired fasting glucose, single-nucleotide polymorphisms, and risk for colorectal cancer in Koreans.

Authors:  Keum Ji Jung; Miyong To Kim; Sun Ha Jee
Journal:  Epidemiol Health       Date:  2016-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.